Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thiazolidinediones and clinical outcomes in type 2 diabetes.

× No keyword cloud information.

9 in total

Review 1. Meta-analysis: A brief introduction.

Authors: Jocelyn A Andrel; Scott W Keith; Benjamin E Leiby
Journal: Clin Transl Sci Date: 2009-10 Impact factor: 4.689

2. When is evidence of lack of harm enough? Has the rosiglitazone controversy ended?

Authors: Anthony L McCall
Journal: Curr Diab Rep Date: 2009-10 Impact factor: 4.810

Review 3. The diabetic patient in Ramadan.

Authors: Hassan Chamsi-Pasha; Khalid S Aljabri
Journal: Avicenna J Med Date: 2014-04

4. Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Authors: Richard G Bach; Maria Mori Brooks; Manuel Lombardero; Saul Genuth; Thomas W Donner; Alan Garber; Laurence Kennedy; E Scott Monrad; Rodica Pop-Busui; Sheryl F Kelsey; Robert L Frye
Journal: Circulation Date: 2013-07-15 Impact factor: 29.690

Review 5. Cardiovascular effects of anti-diabetes drugs.

Authors: Lisa M Younk; Elizabeth M Lamos; Stephen N Davis
Journal: Expert Opin Drug Saf Date: 2016-06-27 Impact factor: 4.250

6. Recommendations for management of diabetes during Ramadan: update 2010.

Authors: Monira Al-Arouj; Samir Assaad-Khalil; John Buse; Ibtihal Fahdil; Mohamed Fahmy; Sherif Hafez; Mohamed Hassanein; Mahmoud Ashraf Ibrahim; David Kendall; Suhail Kishawi; Abdulrazzaq Al-Madani; Abdullah Ben Nakhi; Khaled Tayeb; Abraham Thomas
Journal: Diabetes Care Date: 2010-08 Impact factor: 17.152

Thiazolidinediones and clinical outcomes in type 2 diabetes.

Review 1. Meta-analysis: A brief introduction.

2. When is evidence of lack of harm enough? Has the rosiglitazone controversy ended?

Review 3. The diabetic patient in Ramadan.

4. Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Review 5. Cardiovascular effects of anti-diabetes drugs.

6. Recommendations for management of diabetes during Ramadan: update 2010.

7. Impact of rosiglitazone meta-analysis on use of glucose-lowering medications.

8. Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan.

Review 9. Options for Controlling Type 2 Diabetes during Ramadan.